Designing a broad-spectrum integrative approach for cancer prevention and treatment. (December 2015)
- Record Type:
- Journal Article
- Title:
- Designing a broad-spectrum integrative approach for cancer prevention and treatment. (December 2015)
- Main Title:
- Designing a broad-spectrum integrative approach for cancer prevention and treatment
- Authors:
- Block, Keith I.
Gyllenhaal, Charlotte
Lowe, Leroy
Amedei, Amedeo
Amin, A.R.M. Ruhul
Amin, Amr
Aquilano, Katia
Arbiser, Jack
Arreola, Alexandra
Arzumanyan, Alla
Ashraf, S. Salman
Azmi, Asfar S.
Benencia, Fabian
Bhakta, Dipita
Bilsland, Alan
Bishayee, Anupam
Blain, Stacy W.
Block, Penny B.
Boosani, Chandra S.
Carey, Thomas E.
Carnero, Amancio
Carotenuto, Marianeve
Casey, Stephanie C.
Chakrabarti, Mrinmay
Chaturvedi, Rupesh
Chen, Georgia Zhuo
Chen, Helen
Chen, Sophie
Chen, Yi Charlie
Choi, Beom K.
Ciriolo, Maria Rosa
Coley, Helen M.
Collins, Andrew R.
Connell, Marisa
Crawford, Sarah
Curran, Colleen S.
Dabrosin, Charlotta
Damia, Giovanna
Dasgupta, Santanu
DeBerardinis, Ralph J.
Decker, William K.
Dhawan, Punita
Diehl, Anna Mae E.
Dong, Jin-Tang
Dou, Q. Ping
Drew, Janice E.
Elkord, Eyad
El-Rayes, Bassel
Feitelson, Mark A.
Felsher, Dean W.
Ferguson, Lynnette R.
Fimognari, Carmela
Firestone, Gary L.
Frezza, Christian
Fujii, Hiromasa
Fuster, Mark M.
Generali, Daniele
Georgakilas, Alexandros G.
Gieseler, Frank
Gilbertson, Michael
Green, Michelle F.
Grue, Brendan
Guha, Gunjan
Halicka, Dorota
Helferich, William G.
Heneberg, Petr
Hentosh, Patricia
Hirschey, Matthew D.
Hofseth, Lorne J.
Holcombe, Randall F.
Honoki, Kanya
Hsu, Hsue-Yin
Huang, Gloria S.
Jensen, Lasse D.
Jiang, Wen G.
Jones, Lee W.
Karpowicz, Phillip A.
Keith, W. Nicol
Kerkar, Sid P.
Khan, Gazala N.
Khatami, Mahin
Ko, Young H.
Kucuk, Omer
Kulathinal, Rob J.
Kumar, Nagi B.
Kwon, Byoung S.
Le, Anne
Lea, Michael A.
Lee, Ho-Young
Lichtor, Terry
Lin, Liang-Tzung
Locasale, Jason W.
Lokeshwar, Bal L.
Longo, Valter D.
Lyssiotis, Costas A.
MacKenzie, Karen L.
Malhotra, Meenakshi
Marino, Maria
Martinez-Chantar, Maria L.
Matheu, Ander
Maxwell, Christopher
McDonnell, Eoin
Meeker, Alan K.
Mehrmohamadi, Mahya
Mehta, Kapil
Michelotti, Gregory A.
Mohammad, Ramzi M.
Mohammed, Sulma I.
Morre, D. James
Muralidhar, Vinayak
Muqbil, Irfana
Murphy, Michael P.
Nagaraju, Ganji Purnachandra
Nahta, Rita
Niccolai, Elena
Nowsheen, Somaira
Panis, Carolina
Pantano, Francesco
Parslow, Virginia R.
Pawelec, Graham
Pedersen, Peter L.
Poore, Brad
Poudyal, Deepak
Prakash, Satya
Prince, Mark
Raffaghello, Lizzia
Rathmell, Jeffrey C.
Rathmell, W. Kimryn
Ray, Swapan K.
Reichrath, Jörg
Rezazadeh, Sarallah
Ribatti, Domenico
Ricciardiello, Luigi
Robey, R. Brooks
Rodier, Francis
Rupasinghe, H.P. Vasantha
Russo, Gian Luigi
Ryan, Elizabeth P.
Samadi, Abbas K.
Sanchez-Garcia, Isidro
Sanders, Andrew J.
Santini, Daniele
Sarkar, Malancha
Sasada, Tetsuro
Saxena, Neeraj K.
Shackelford, Rodney E.
Shantha Kumara, H.M.C.
Sharma, Dipali
Shin, Dong M.
Sidransky, David
Siegelin, Markus David
Signori, Emanuela
Singh, Neetu
Sivanand, Sharanya
Sliva, Daniel
Smythe, Carl
Spagnuolo, Carmela
Stafforini, Diana M.
Stagg, John
Subbarayan, Pochi R.
Sundin, Tabetha
Talib, Wamidh H.
Thompson, Sarah K.
Tran, Phuoc T.
Ungefroren, Hendrik
Vander Heiden, Matthew G.
Venkateswaran, Vasundara
Vinay, Dass S.
Vlachostergios, Panagiotis J.
Wang, Zongwei
Wellen, Kathryn E.
Whelan, Richard L.
Yang, Eddy S.
Yang, Huanjie
Yang, Xujuan
Yaswen, Paul
Yedjou, Clement
Yin, Xin
Zhu, Jiyue
Zollo, Massimo
… (more) - Abstract:
- Abstract: Targeted therapies and the consequent adoption of "personalized" oncology have achieved notable successes in some cancers; however, significant problems remain with this approach. Many targeted therapies are highly toxic, costs are extremely high, and most patients experience relapse after a few disease-free months. Relapses arise from genetic heterogeneity in tumors, which harbor therapy-resistant immortalized cells that have adopted alternate and compensatory pathways (i.e., pathways that are not reliant upon the same mechanisms as those which have been targeted). To address these limitations, an international task force of 180 scientists was assembled to explore the concept of a low-toxicity "broad-spectrum" therapeutic approach that could simultaneously target many key pathways and mechanisms. Using cancer hallmark phenotypes and the tumor microenvironment to account for the various aspects of relevant cancer biology, interdisciplinary teams reviewed each hallmark area and nominated a wide range of high-priority targets (74 in total) that could be modified to improve patient outcomes. For these targets, corresponding low-toxicity therapeutic approaches were then suggested, many of which were phytochemicals. Proposed actions on each target and all of the approaches were further reviewed for known effects on other hallmark areas and the tumor microenvironment. Potential contrary or procarcinogenic effects were found for 3.9% of the relationships between targetsAbstract: Targeted therapies and the consequent adoption of "personalized" oncology have achieved notable successes in some cancers; however, significant problems remain with this approach. Many targeted therapies are highly toxic, costs are extremely high, and most patients experience relapse after a few disease-free months. Relapses arise from genetic heterogeneity in tumors, which harbor therapy-resistant immortalized cells that have adopted alternate and compensatory pathways (i.e., pathways that are not reliant upon the same mechanisms as those which have been targeted). To address these limitations, an international task force of 180 scientists was assembled to explore the concept of a low-toxicity "broad-spectrum" therapeutic approach that could simultaneously target many key pathways and mechanisms. Using cancer hallmark phenotypes and the tumor microenvironment to account for the various aspects of relevant cancer biology, interdisciplinary teams reviewed each hallmark area and nominated a wide range of high-priority targets (74 in total) that could be modified to improve patient outcomes. For these targets, corresponding low-toxicity therapeutic approaches were then suggested, many of which were phytochemicals. Proposed actions on each target and all of the approaches were further reviewed for known effects on other hallmark areas and the tumor microenvironment. Potential contrary or procarcinogenic effects were found for 3.9% of the relationships between targets and hallmarks, and mixed evidence of complementary and contrary relationships was found for 7.1%. Approximately 67% of the relationships revealed potentially complementary effects, and the remainder had no known relationship. Among the approaches, 1.1% had contrary, 2.8% had mixed and 62.1% had complementary relationships. These results suggest that a broad-spectrum approach should be feasible from a safety standpoint. This novel approach has potential to be relatively inexpensive, it should help us address stages and types of cancer that lack conventional treatment, and it may reduce relapse risks. A proposed agenda for future research is offered. … (more)
- Is Part Of:
- Seminars in cancer biology. Volume 35(2016)Supplement
- Journal:
- Seminars in cancer biology
- Issue:
- Volume 35(2016)Supplement
- Issue Display:
- Volume 35, Issue 2016 (2016)
- Year:
- 2016
- Volume:
- 35
- Issue:
- 2016
- Issue Sort Value:
- 2016-0035-2016-0000
- Page Start:
- S276
- Page End:
- S304
- Publication Date:
- 2015-12
- Subjects:
- Multi-targeted -- Cancer hallmarks -- Phytochemicals -- Targeted therapy -- Integrative medicine
Cancer -- Periodicals
Neoplasms -- Periodicals
Review Literature
Cancer -- Périodiques
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/1044579X ↗
http://www.clinicalkey.com/dura/browse/journalIssue/1044579X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/1044579X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.semcancer.2015.09.007 ↗
- Languages:
- English
- ISSNs:
- 1044-579X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8239.448340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23961.xml